Home > Events > Meet veristat at raps convergence 2026

1 min read

Meet Veristat at RAPS Convergence 2026

Where Regulatory Strategy Meets What’s Next

RAPS Convergence US: September 15-17, 2026 – Charlotte, NC

Veristat is pleased to attend RAPS Convergence 2026, where regulatory professionals, health authority representatives, and industry leaders come together to discuss the evolving requirements shaping healthcare product development. With more than 100 sessions spanning pharmaceuticals, biologics, medical devices, and other emerging areas, this year’s meeting puts regulatory innovation and collaboration at the center of the conversation.

We’re looking forward to connecting with regulatory leaders in Charlotte to discuss the challenges sponsors are navigating across increasingly complex global development programs. Veristat brings regulatory strategy together with clinical development, biometrics, and medical writing expertise to anticipate requirements, strengthen development strategies, and build a clearer path toward successful submissions and approvals.

Meet with Us
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Angie Gray, Senior Manager, Regulatory Operations

Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy. 

Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:

  • Clinical Operations Excellence
  • Global Regulatory Strategy & Submissions
  • Full-Service Clinical Development Solutions

If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.

 

Share This Event:

   

8 min read

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...

1 min read

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...